Tricuspid Valve Disease clinical trials at UC Davis
1 research study open to eligible people
open to eligible people ages 1-70
To demonstrate the proof of principle and initial clinical safety of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve) and increase the efficiency of the device development process by identifying appropriate modifications to the implant procedure or the device.
Indianapolis, Indiana and other locations